Anthony J. Comerota
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anthony J. Comerota has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Subhash Thakur
Jobst Vascular Institute, The Toledo Hospital, Toledo, Ohio
6 shared publicationsRamandeep Sidhu
Jobst Vascular Center, Toledo, OH, USA
2 shared publicationsZakaria Assi
Jobst Vascular Institute, Toledo, OH
2 shared publicationsAngie Link
1 shared publicationD. Paolini
1 shared publicationDavid Vogel
Jobst Vascular Institute, Toledo, Ohio, USA
1 shared publication
Latest Publications
- 1 March 2015
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 61 (3) , 796-799
Lumbar artery pseudoaneurysm in a patient with inferior vena cava filter and history of strenuous physical exercise
- 1 March 2015
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 61 (3) , 796-799
Lumbar artery pseudoaneurysm in a patient with inferior vena cava filter and history of strenuous physical exercise
- 1 October 2014
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 28 (7) , 1589-1594
Catheter-Directed Thrombolytic Intervention Is Effective for Patients with Massive and Submassive Pulmonary Embolism
- 1 October 2014
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 28 (7) , 1589-1594
Catheter-Directed Thrombolytic Intervention Is Effective for Patients with Massive and Submassive Pulmonary Embolism
- 1 February 2014
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 59 (2) , 456-464
Managing iliofemoral deep venous thrombosis of pregnancy with a strategy of thrombus removal is safe and avoids post-thrombotic morbidity
- 1 February 2014
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 59 (2) , 456-464
Managing iliofemoral deep venous thrombosis of pregnancy with a strategy of thrombus removal is safe and avoids post-thrombotic morbidity
- 27 October 2012
- Published by Springer Nature
- p. 389-402
Deep Venous Thrombosis: Upper and Lower Extremity
- 27 October 2012
- Published by Springer Nature
- p. 389-402
Deep Venous Thrombosis: Upper and Lower Extremity
- 4 July 2012
- Published by Springer Nature
- p. 173-181
Role of Duplex Ultrasound in Carotid Screening
- 17 April 2012
- Published by BMJ in BMJ Evidence-Based Medicine
- Vol. 17 (6) , 182-183
Catheter-directed thrombolysis prevents post-thrombotic syndrome in patients with acute deep vein thrombosis in the upper half of the thigh
- 17 April 2012
- Published by BMJ in BMJ Evidence-Based Medicine
- Vol. 17 (6) , 182-183
Catheter-directed thrombolysis prevents post-thrombotic syndrome in patients with acute deep vein thrombosis in the upper half of the thigh
- 1 March 2012
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 27 (1_suppl) , 95-102
The Future of Deep Venous Thrombosis and Post-thrombotic Syndrome in 2020
This manuscript addresses six major issues involving deep venous thrombosis (DVT) and post-thrombotic syndrome. Prevention will likely see modest advances in pharmacological therapy mainly by extending prophylaxis in high-risk patients. More notable advances will be observed in mechanical means of prophylaxis, focusing on sustained application of devices that can move larger volumes of blood. Silent, large-vein thrombi continue to place patients at risk for fatal pulmonary embolism. Improved imaging techniques will permit us to identify these patients over the next eight years. In many of those patients, vena caval interruption will be required. Elimination of high-risk filters and the production of improved filters placed through low-profile systems with antithrombotic agents bound to their surface will improve the short- and long-term results for inferior vena cava filters. The long-term management of DVT will focus on establishing appropriate duration for the individual patient and will see the evolution towards direct Xa and Ha inhibitors. Patients with extensive DVT will more commonly receive treatment strategies designed to eliminate thrombus and restore patency. This will substantially reduce post-thrombotic morbidity and reduce recurrence. Post-thrombotic syndrome will see greater attention towards treating the intraluminal fibrosis, thereby eliminating post-thrombotic venous obstruction. Unfortunately, neovalves will still be searching for the appropriate application.
- 1 March 2012
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 27 (1_suppl) , 95-102
The Future of Deep Venous Thrombosis and Post-thrombotic Syndrome in 2020
This manuscript addresses six major issues involving deep venous thrombosis (DVT) and post-thrombotic syndrome. Prevention will likely see modest advances in pharmacological therapy mainly by extending prophylaxis in high-risk patients. More notable advances will be observed in mechanical means of prophylaxis, focusing on sustained application of devices that can move larger volumes of blood. Silent, large-vein thrombi continue to place patients at risk for fatal pulmonary embolism. Improved imaging techniques will permit us to identify these patients over the next eight years. In many of those patients, vena caval interruption will be required. Elimination of high-risk filters and the production of improved filters placed through low-profile systems with antithrombotic agents bound to their surface will improve the short- and long-term results for inferior vena cava filters. The long-term management of DVT will focus on establishing appropriate duration for the individual patient and will see the evolution towards direct Xa and Ha inhibitors. Patients with extensive DVT will more commonly receive treatment strategies designed to eliminate thrombus and restore patency. This will substantially reduce post-thrombotic morbidity and reduce recurrence. Post-thrombotic syndrome will see greater attention towards treating the intraluminal fibrosis, thereby eliminating post-thrombotic venous obstruction. Unfortunately, neovalves will still be searching for the appropriate application.
- 1 March 2012
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 25 (1) , 2-12
The Current Role of Operative Venous Thrombectomy in Deep Vein Thrombosis
- 1 March 2012
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 25 (1) , 2-12
The Current Role of Operative Venous Thrombectomy in Deep Vein Thrombosis
- 1 January 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (1) , 129-135
Common femoral endovenectomy with iliocaval endoluminal recanalization improves symptoms and quality of life in patients with postthrombotic iliofemoral obstruction
- 1 January 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (1) , 129-135
Common femoral endovenectomy with iliocaval endoluminal recanalization improves symptoms and quality of life in patients with postthrombotic iliofemoral obstruction
- 1 August 2011
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (2) , 607-611
Thrombolysis for deep venous thrombosis
- 1 August 2011
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (2) , 607-611
Thrombolysis for deep venous thrombosis